{"ModuleTitle": "Company Description", "CompanyName": "Alkermes plc", "Symbol": "ALKS", "Address": "852 WINTER STREET, WALTHAM, Massachusetts, 02451-1420, Ireland", "Phone": "(781)609-6000", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "Europe", "CompanyDescription": "The following discussion contains forward\u00adlooking statements. Actual results may\r\ndiffer significantly from those expressed or implied in the forward\u00adlooking\r\nstatements. See \"Cautionary Note Concerning Forward\u00adLooking Statements\" on\r\npage 3 in this Annual Report. Factors that might cause future results to differ\r\nmaterially from those expressed or implied in the forward\u00adlooking statements\r\ninclude, but are not limited to, those discussed in \"Item 1A--Risk Factors\" and\r\nelsewhere in this Annual Report.\r\n\r\nOverview\r\n\r\nAlkermes plc is a fully integrated, global biopharmaceutical company that\r\napplies its scientific expertise and proprietary technologies to research,\r\ndevelop and commercialize, both with partners and on its own, pharmaceutical\r\nproducts that are designed to address unmet medical needs of patients in major\r\ntherapeutic areas.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f13%2f0001564590-20-004489.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Craig C. Hopkinson", "title": "Chief Medical Officer & EVP-Research & Development"}, {"name": "Declan O'Connor", "title": "Senior Vice President-Operations"}, {"name": "James M. Frates", "title": "Chief Financial Officer & Senior Vice President"}, {"name": "Richard F. Pops", "title": "Chairman & Chief Executive Officer"}, {"name": "Sondra Smyrnios", "title": "Senior Vice President-Clinical Operations"}, {"name": "Thomas Harvey", "title": "Chief Information Officer & Senior VP-IT"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}